Biallelic loss-of-function mutations in the DOCK2 gene are associated with clinical features of combined immunodeficiency (CID) according to the primary immunodeficiency (PID) treatment consortium (PIDTC) [3, 4]. This evidence concerns the gene DOCK2 and combined immunodeficiency.